Hyperandrogenemia: Pathophysiology and its role in ovulatory dysfunction in PCOS

Pediatric Endocrinology Reviews

Volumn 3, Issue SUPPL. 1, 2006, Pages 198-204

  Diamanti Kandarakis, Evanthia ^a,b   Papailiou, Joanna ^a   Palimeri, Sotiria ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b NONE   (Greece)

Author keywords

Anovulation; Hyperandrogenemia; Infertility; Ovulatory dysfunction; PCOS

Indexed keywords

ANOVULATION; CONFERENCE PAPER; EARLY DIAGNOSIS; ENDOCRINE DISEASE; HUMAN; HYPERANDROGENISM; INFERTILITY; OVARY INSUFFICIENCY; OVARY POLYCYSTIC DISEASE; PATHOPHYSIOLOGY; PUBERTY;

ADOLESCENT; ADULT; ANDROGENS; ANOVULATION; FEMALE; HUMANS; HYPERANDROGENISM; INFERTILITY, FEMALE; OVARIAN FOLLICLE; POLYCYSTIC OVARY SYNDROME;

EID: 33645418021     PISSN: 15654753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (58)

1. Smith KD, Rodriguez-Rigau Lj, Tcholakian RK, Steinberger E. The relation between plasma testosterone levels and the lengths of phases of the menstrual cycle. Fertil Steril 1979;32:403-407
2. Rodriguez-Rigou LJ, Petak SM, Leite Z, Smith KD, Steinberger E. Therapy of hyperandrogenism. In: Frajese G, Steinberger E, Rodriguez-Rigau LJ, (eds) Reproductive medicine: Medical therapy. Amsterdam: Excerpta Medica, 1989:69-77
3. Steinberger E, Smith KD, Tcholakian RK, Rodriguez-Rigau LJ. Testosterone levels in female partners of infertile couples. Am J Obset Gynecol 1979;133:133-138
4. Apter D, Vihko R. Endocrine determinants of fertility: Serum androgen concentrations during follow-up of adolescents into the third decade of life. J Clin Endocrinol Metab 1990;71:970-974
5. Steinberger E, Smith KD, Rodriguez-Rigau LJ. Testosterone, dehydroepiandrosterone, and dehydroepiandrosterone sulfate in hyperandrogenic women. J Clin Endocrinol Metab 1984;59:471-477
6. Smith KD, Rodriguez-Rigau LJ, Tcholakian RK, Steinberger E. The relation between plasma testosterone levels and the lengths of phases of the menstrual cycle. Fertil Steril 1979;32:403-407
7. Steinberger E, Smith KD, Tcholakian RK, Rodriguez-Rigau LJ. Testosterone levels in female partners of infertile couples: relationship between androgen levels in the woman, the male factor, and the incidence of pregnancy. Am J Obstet Gynecol 1979;133:133-138
8. Erickson GF, Magoffin DA, Dyer CA, Hofeditz C. The ovarian Androgen Producing Cells: A Review of Structure / Function Relationships. Endocr Rev 1985;6:371-399
9. Willis DS, Watson H, Mason HD, Galea R, Brincat M, Franks S. Premature response to luteinizing hormone of granulosa cells from anovulatory women with polycystic ovary syndrome: relevance to mechanism of anovulation. J Clin Endocrinol Metab 1998;83:3984-3991
10. Diamanti-Kandarakis E, Kouli CR, Bergiele AT, Filandra FA, Tsianateli TC, Spina GG, Zapanti ED, Bartzis MI. A survey of the PCOS in the Greek island of Lesbos: Hormonal and metabolic profile. J Clin Endocrinol Metab 1999;84:4006-4011
11. Gilling-Smith C, Willis D, Franks S. Oestradiol feedback stimulation of androgen biosynthesis by human theca cells. Hum Reprod 1997;12:1621-1628
12. Mason HD, Willis DS, Beard RW, Winston RM, Margara R, Franks S. Estradiol production by granulosa cells of normal and polycystic ovaries: relationship to menstrual cycle history and concentrations of gonadotropins and sex steroids in follicular fluid. J Clin Endocrinol Metab 1994;79:1355-1360
13. Franks S, Mason H, White D, Willis D. Etiology of anovulation in polycystic ovary syndrome. Steroids 1998;63:306-307
14. Gilling-Smith C, Willis DS, Beard RW, Franks S. Hypersecretion of androstenedione by isolated theca cells from polycystic ovaries. J Clin Endocrinol Metab 1994;79:1158-1165
15. Elting MW, Korsen TJ, Rekers-Mombarg LT, Schoemaker J. Women with polycystic ovary syndrome gain regular menstrual cycles when ageing. Hum Reprod 2000;15:24-28
16. Elting MW, Kwee J, Korsen TJ, Rekers-Mombarg LT, Schoemaker J. Aging women with polycystic ovary syndrome who achieve regular menstrual cycles have a smaller follicle cohort than those who continue to have irregular cycles. Fertil Steril 2003;79:1154-1160
17. Willis DS, Willis D, Watson H, Mason HD, Galea R, Brincat M, Franks S. Premature response to luteinizing hormone of granulosa cells from anovulatory women with polycystic ovary syndrome: relevance to mechanism of anovulation. J Clin Endocrinol Metab 1998;83:3984-3991
18. Jakimiuk AJ, Weitsman SR, Navab A, Macoffin DA. Luteinizing hormone receptor, steroidogenesis acute regulatory protein, and steroidogenic enzyme messenger ribonucleic acids are overexpressed in thecal and granulosa cells from polycystic ovaries. J Clin Endocrinol Metab 2001;86:1318-1323
19. Nestler JE, Jakubowicz DJ. Decrease in ovarian cytochrome P450c17alpha activity and serum free testosterone after reduction in insulin secretion in women with polycystic ovarian syndrome. N Engl J Med 1996;335:617-623
20. Abbott DH, Dumesic DA, Eisner JR, Colman RJ, Kemnitz JW. Polycystic Ovary Syndrome (PCOS) from studies of prenatally androgenized female rhesus monkeys trends. Endocrinol Metab 1998;9:62-67
21. Vendola KA, Zhou J, Adesanya OO, Weil SJ, Bondy CA. Androgens stimulate early stages of follicular growth in the primate ovary. J Clin Invest 1998;101:2622-2629
22. Abbott DH, Dumesic DA, Franks S. Developmental origin of polycystic ovary syndrome - a hypothesis. J Endocrinol 2002;174:1-5
23. Poretsky L, Role of insulin resistance in the pathogenesis of the polycystic ovaries syndrome. In: Schats R, Schoemaker J, (eds) Ovarian Endocrinopathies. London, Parthenon Publishing, 1994:169-177
24. Nestler JE, Strauss JF III. Insulin as an effector of human ovarian and adrenal steroid metabolism. Endocrinol Metab Clin North Am 1991;20:807-823
25. Poretsky L, Kalin MF. The gonadotropic function of insulin. Endocr Rev 1987;8:132-137
26. Bergh C, Carlsson B, Olsson J-H, Selleskog U, Hillensjo T. Regulation of androgen production in cultured human thecal cells by insulin-like growth factor I and insulin. Fertil Steril 1993;59:323-327
27. Conover CA, Lee PDK, Kanaley JA, Clarkson JT, Jensen MD. Insulin regulation of insulin -like growth factor binding protein-I in obese and non-obese humans. J Clin Endocrinol Metab 1992;74:1355-1357
28. Poretsky L, Cataldo NA, Rosenwaks Z, Giudice LC. The insulin-related ovarian regulatory system in health and disease. Endocr Rev 1999;20:535-582
29. Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 1997;18:774-800
30. Nestler JE, Jakubowicz DJ, de Vargas AF, Brik C, Quintero N, Medina F. Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system. J Clin Endocrinol Metab 1998;83:2001-2005
31. Barnes RB. The pathogenesis of polycystic ovary syndrome: lessons from ovarian stimulation studies. J Endocrinol Invest 1998;21:567-579
32. Nestler JC, Barlascini CO, Matt DW, Steingold KA, Plymate SR, Clore JN, Blackard WG. Suppression of serum insulin by diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab 1989;68:1027
33. Nestler JE, Jakubowicz DJ. Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome. N Engl J Med 1996;335:617-623
34. Legro RS, Spielman R, Urbanek M, Driscoll D, Strauss JF III, Dunaif A. Phenotype and genotype in polycystic ovary syndrome. Recent Prog Horm Res 1998;53:217-256
35. Franks S, Gharani N, Waterworth D, Batty S, White D, Williamson R, McCarthy M. Genetics of polycystic ovary syndrome. Mol Cell Endocrinol 1998;145:123-128
36. Wickenheisser JK, Quinn PG, Nelson VL, Legro RS, Strauss JF, McAllister JM. Differential activity of the cytochrome P450 17a-hydroxylase and steroidogenic acute regulatory protein gene promoters in normal and polycystic ovary syndrome theca cells. J Clin Endocrinol Metab 2000;85:2304-2311
37. Nelson VL, Legro RS, Strauss JF III. McAllister JM. Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries. Mol Endocrinol 1999;13:946-957
38. Gharani N, Waterworth DM, Williamson R, Franks S. 5-polymorphism of the CYP17 gene is not associated with serum testosterone levels in women with polycystic ovaries. J Clin Endocrinol Metab 1996;81:4174-4180
39. Gharani N, Waterworth D, Batty S, White D, Gilling-Smith C, Conway G, McCarthy, M, Franks S, Williamson R. Association of the steroid synthesis gene CYP11a with polycystic ovary syndrome and hyperandrogenism. Hum Mol Genet 1997;3:397-402
40. SanMillan JL, Sancho J, Calvo RM, Escobar-Morreale HF. Role of the pentanucleotide (tttta)n polymorphism in the promoter of the CYP11a gene in the pathogenesis of hirsutism. Fertil Steril 2001;75:797-802
41. Strauss JF III, Wood JR, Christenson LK, McAllister JM. Strategies to elucidate the mechanism of excessive theca cell androgen production in PCOS. Mol Cell Endocrinol 2002; 186:183-188
42. Wood JR, Nelson VL, Ho C, Jansen E, Wang CY, Urbanek M, McAllister JM, Mosselman S, Strauss JF 3rd. The molecular phenotype of polycystic ovary syndrome (PCOS) theca cells and new candidate PCOS genes defined by microarray analysis. J Biol Chem 2003;278:26380-26390
43. Hillier SG, Yong EL, Illingworth PJ, Baird DT, Schwall RH, Mason AJ. Effect of recombinant inhibin on androgen synthesis in cultured human thecal cells. Mol Cell Endocrinol 1991;75:R1-R6
44. Pigny P, Desailloud R, Cortet-Rudelli C, Duhamel A, Deroubaix-Allard D, Racadot A, Dewailly D. Serum a-inhibin levels in PCOS: relationship to the serum androstenedione level. J Clin Endocrinol Metab 1997;82:1939-1943
45. Pigny P, Cortet-Rudelli C, Decanter C, Deroubaix D, Soudan B, Duhamel A, Dewailly D. Serum levels of inhibins are differentially altered in patients with PCOS: effects of being overweight and relevance to hyperandrogenism. Fertil Steril 2000;73:972-977
46. Solovyeva EV, Hayashi M, Margi K, Barkats C, Klein C, Amsterdam A, Hsueh AJ, Tsafriri A. Growth differentiation factor-9 stimulates rat theca-interstitial cell androgen biosynthesis. Biol Reprod 2000;63:1214-1218
47. TeixeiraFilho FL, Baracat EC, Lee TH, Suh CS, Matsui M, Chang RJ, Shimasaki S Erickson GF. Aberrant expression of growth differentiation factor-9 in oocytes of women with polycystic ovary syndrome. J Clin Endocrinol Metab 2002;87:1337-1344
48. Cook CL, Siow Y, Brenner Ag, Fallat ME. Relationship between serum mullerian-inhibiting substance and other reproductive hormones in untreated women with polycystic ovary syndrome and normal women. Fertil Steril 2002;77:141-146
49. Laven JS, Mulders AG, Themmen AP, de Jong FH, Fauser BC. Anti-MuÈllerian Hormone (AMH) serum concentrations in normoovulatory and anovulatory women. J Clin Endocrinol Metab 2004;89:318-323
50. Sophie Jonard Didier Dewailly. The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest. Human Repr Update 2004;10:107-117
51. Diamanti-Kandarakis E. Current aspects of antiandrogen therapy in women. Curr Pharma Design 1999;5:707-723
52. Maroulis GB, Abraham GE. Diagnostic tests in hirsutism. In: Mahesh VB, Greenblatt RB, (eds) Hirsutism and virilism. Pathogenesis, diagnosis and management. Boston, John Wright PSG, 1983;295-307
53. Dumesic DA Hormonal evaluation of androgen excess. In: Azziz R, Nestler J, Dewailly D, (eds) Androgen excess disorders in women. New York, Lippincott-Raven, 1997;635-646
54. Pittaway DE Neoplastic causes of hyperandrogenism. Infertil Reprod Med Clin North Am, 1991;2:531-541
55. Lobo RA. Ovarian hyperandrogenism and androgen-producing tumors. Endocrinol Metab Clin North Am 1991;20:773-805
56. Dewailly D, Vantyghem-Haudiquet MC, Sainsard C, Buvat J, Cappoen JP, Ardaens K, Racadot A, Lefebvre J, Fossati P. Clinical and biological phenotypes in late-onset 21-hydroxytase deficiency. J Clin Endocrinol Metab 1986;63:418-423
57. Camina E, Rosato F, Maggiore M, Cagliano AM, Indovina D, Janni A. Prolactin secretion in polycystic ovary syndrome (PCO): correlation with the steroid pattern. Acta Endocrinol (Copenh) 1984;105:99-104
58. Rittmaster RS. Clinical relevance of testosterone and dihydrotestosterone metabolism in women. Am J Med 1995;98: IA17S-IA21S